220 related articles for article (PubMed ID: 28249240)
1. Identification of novel dual-specificity phosphatase 26 inhibitors by a hybrid virtual screening approach based on pharmacophore and molecular docking.
Ren JX; Cheng Z; Huang YX; Zhao JF; Guo P; Zou ZM; Xie Y
Biomed Pharmacother; 2017 May; 89():376-385. PubMed ID: 28249240
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of dual-specificity phosphatase 26 by ethyl-3,4-dephostatin: Ethyl-3,4-dephostatin as a multiphosphatase inhibitor.
Seo H; Cho S
Pharmazie; 2016 Apr; 71(4):196-200. PubMed ID: 27209699
[TBL] [Abstract][Full Text] [Related]
3. Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26.
Won EY; Lee SO; Lee DH; Lee D; Bae KH; Lee SC; Kim SJ; Chi SW
PLoS One; 2016; 11(9):e0162115. PubMed ID: 27583453
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel DUSP16 phosphatase inhibitors through virtual screening with homology modeled protein structure.
Park H; Park SY; Nam SW; Ryu SE
J Biomol Screen; 2014 Dec; 19(10):1383-90. PubMed ID: 25245988
[TBL] [Abstract][Full Text] [Related]
5. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
6. NSC-87877, inhibitor of SHP-1/2 PTPs, inhibits dual-specificity phosphatase 26 (DUSP26).
Song M; Park JE; Park SG; Lee DH; Choi HK; Park BC; Ryu SE; Kim JH; Cho S
Biochem Biophys Res Commun; 2009 Apr; 381(4):491-5. PubMed ID: 19233143
[TBL] [Abstract][Full Text] [Related]
7. High-resolution crystal structure of the catalytic domain of human dual-specificity phosphatase 26.
Won EY; Xie Y; Takemoto C; Chen L; Liu ZJ; Wang BC; Lee D; Woo EJ; Park SG; Shirouzu M; Yokoyama S; Kim SJ; Chi SW
Acta Crystallogr D Biol Crystallogr; 2013 Jun; 69(Pt 6):1160-70. PubMed ID: 23695260
[TBL] [Abstract][Full Text] [Related]
8. Atomic structure of dual-specificity phosphatase 26, a novel p53 phosphatase.
Lokareddy RK; Bhardwaj A; Cingolani G
Biochemistry; 2013 Feb; 52(5):938-48. PubMed ID: 23298255
[TBL] [Abstract][Full Text] [Related]
9. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
Patterson KI; Brummer T; Daly RJ; O'Brien PM
Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885
[TBL] [Abstract][Full Text] [Related]
10. A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.
Thompson EM; Stoker AW
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466673
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.
Tanuma N; Nomura M; Ikeda M; Kasugai I; Tsubaki Y; Takagaki K; Kawamura T; Yamashita Y; Sato I; Sato M; Katakura R; Kikuchi K; Shima H
Oncogene; 2009 Feb; 28(5):752-61. PubMed ID: 19043453
[TBL] [Abstract][Full Text] [Related]
12. Identification of inhibitors that target dual-specificity phosphatase 5 provide new insights into the binding requirements for the two phosphate pockets.
Neumann TS; Span EA; Kalous KS; Bongard R; Gastonguay A; Lepley MA; Kutty RG; Nayak J; Bohl C; Lange RG; Sarker MI; Talipov MR; Rathore R; Ramchandran R; Sem DS
BMC Biochem; 2015 Aug; 16():19. PubMed ID: 26286528
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel potent human testis-specific and bromodomain-containing protein (BRDT) inhibitors using crystal structure-based virtual screening.
Gao N; Ren J; Hou L; Zhou Y; Xin L; Wang J; Yu H; Xie Y; Wang H
Int J Mol Med; 2016 Jul; 38(1):39-44. PubMed ID: 27220398
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.
Shang X; Vasudevan SA; Yu Y; Ge N; Ludwig AD; Wesson CL; Wang K; Burlingame SM; Zhao YJ; Rao PH; Lu X; Russell HV; Okcu MF; Hicks MJ; Shohet JM; Donehower LA; Nuchtern JG; Yang J
Oncogene; 2010 Sep; 29(35):4938-46. PubMed ID: 20562916
[TBL] [Abstract][Full Text] [Related]
15. Identification of potent VHZ phosphatase inhibitors with structure-based virtual screening.
Park H; Park SY; Oh JJ; Ryu SE
J Biomol Screen; 2013 Feb; 18(2):226-31. PubMed ID: 23042075
[TBL] [Abstract][Full Text] [Related]
16. Toward a molecular understanding of the interaction of dual specificity phosphatases with substrates: insights from structure-based modeling and high throughput screening.
Bakan A; Lazo JS; Wipf P; Brummond KM; Bahar I
Curr Med Chem; 2008; 15(25):2536-44. PubMed ID: 18855677
[TBL] [Abstract][Full Text] [Related]
17. Dual Specificity Phosphatase 5-Substrate Interaction: A Mechanistic Perspective.
Kutty RG; Talipov MR; Bongard RD; Lipinski RAJ; Sweeney NL; Sem DS; Rathore R; Ramchandran R
Compr Physiol; 2017 Sep; 7(4):1449-1461. PubMed ID: 28915331
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase.
Palakurti R; Vadrevu R
Comput Biol Chem; 2017 Jun; 68():107-117. PubMed ID: 28288354
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
[TBL] [Abstract][Full Text] [Related]
20. Dual-specificity phosphatase 26 (DUSP26) stimulates Aβ42 generation by promoting amyloid precursor protein axonal transport during hypoxia.
Jung S; Nah J; Han J; Choi SG; Kim H; Park J; Pyo HK; Jung YK
J Neurochem; 2016 Jun; 137(5):770-81. PubMed ID: 26924229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
